Cited by 18Mesenchymal stem cell researchTissue Engineering and Regenerative MedicineCongenital heart defects research

Update on cardiac stem cell therapy in heart failure

Donndorf, Peter, Strauer, Bodo-Eckehard, Steinhoff, Gustav·2012·Current Opinion in Cardiology

Abstract

PURPOSE OF REVIEW: Presentation of the current status of cardiac stem cell therapy for the treatment of ischaemic heart failure by highlighting recent clinical results and introducing ongoing trials. Furthermore, necessary upcoming procedural adjustments are discussed. RECENT FINDINGS: During the last decade, stem cell application in the setting of ischaemic heart failure has been evaluated in phase I and II clinical trials, proving safety and feasibility of this approach. Functional results gained so far indicate moderate benefits. However, conclusive evaluation of cell therapy will not be possible before completion of ongoing phase III multicentre trials. Moreover, questions regarding the optimal cell population for treatment in a chronic setting and the favourable time-point of cell delivery have not been ultimately answered. SUMMARY: Cell therapy for the treatment of ischaemic heart failure needs to be evaluated separately from the setting of acute myocardial infarction. In parallel with upcoming clinical evaluation in large-scale trials, further optimization of the 'cell product' regarding the favourable cell type and periprocedural processing, as well as route and time-point of application, is mandatory.

Integrity signals

Registry

Crossref · 10.1097/hco.0b013e32834fe969

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Donndorf, P., Strauer, B.-E., & Steinhoff, G.
Affiliations
Universitätsmedizin Rostock (DE)
Corresponding author
Donndorf, Peter
Venue
Current Opinion in Cardiology
Published
2012-03
Volume
27
Issue
2
Pages
154-160
ISSN
0268-4705 (ISSN-L)
OpenAlex
W2333769157
Cited by
18
References
39
Citations by year
2021: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2014: 3 · 2013: 4 · 2012: 6
FWCI
0.55
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
Keywords
cardiac stem cell therapy, ischemic heart failure, cell therapy clinical trials, cell processing, feasibility and safety
MeSH terms
Heart Failure, Humans, Treatment Outcome, Myocardial Ischemia, Stem Cell Transplantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review